Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02048878 · ClinicalTrials.gov registry record
Hyper-Arousal in Chronic Primary Insomnia
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 28
- Enrollment target
NCT02048878: Completed study, sponsored by University of Chicago.
NCT02048878 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02048878 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether individuals with chronic insomnia disorder have a higher degree of physiologic arousal (resulting in their trouble sleeping) than good sleepers. The primary goal is to perform a rigorous quantitative assessment of physiologic hyper-arousal across two domains (autonomic nervous system and neurophysiology) in patients with chronic primary insomnia as compared to good sleepers matched for sex, age, body mass index (BMI) and race/ethnicity.
Primary Outcome
Direct recording of sympathetic nervous activity in a nerve of the lower leg using a micro-electrode.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-12-20 |
What the finished NCT02048878 record still lists
NCT02048878 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02048878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02048878 about?
NCT02048878 is a clinical study titled "Hyper-Arousal in Chronic Primary Insomnia". The purpose of this study is to determine whether individuals with chronic insomnia disorder have a higher degree of physiologic arousal (resulting in their trouble sleeping) than good sleepers. The primary goal is to perform a rigorous quantitative assessment of physiologic hyper-arousal across two...
What is the current status of trial NCT02048878?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2014-01. Estimated completion is 2016-12-20.
Who is sponsoring clinical trial NCT02048878?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia